0001772016-26-000007
SEC filingOperating profit fell 32% due to higher product costs, despite 1% net sales growth.
For the three months ended December 31, 2025, BellRing Brands reported net sales of $537.3 million, a 1% increase from $532.9 million in the prior year period. The growth was driven by a 16% surge in Dymatize products, which benefited from 30% higher volumes, particularly in international markets. This was partially offset by a 1% decline in Premier Protein sales, where volumes were flat but average net selling prices decreased due to incremental promotional investment. Operating profit declined sharply by 32% to $78.5 million from $115.3 million, primarily due to $35.9 million in higher net product costs (raw materials and manufacturing). Advertising expenses decreased by $2.7 million, providing some offset. Net earnings fell 43% to $43.7 million, as higher interest expense ($5.6 million increase) and a higher effective tax rate (25.3% vs. 23.8%) further weighed on results. The operating margin contracted to 14.6% from 21.6% in the prior year.
Premier Protein, the largest brand, experienced a slight revenue decline on flat volumes, reflecting competitive promotional pressure. Dymatize showed strong momentum with 16% revenue growth, driven by robust volume gains (30%) despite unfavorable product mix that lowered average selling prices. The all other category contributed a negligible $0.2 million increase. The mix shift towards Dymatize, which carries lower margins, and rising input costs pressured overall profitability.
Management expects inflationary pressures, including the impact of tariffs, to continue adversely affecting operations. They anticipate higher raw material and manufacturing costs, supply chain challenges, and potential consumer demand uncertainty. Despite these headwinds, the company maintains a liquid position with $147.6 million available under its revolving credit facility. Share repurchases of $97.8 million during the quarter reflect management's confidence, but the elevated cost environment remains a near-term risk. No formal guidance was provided, but the company highlighted its asset-light model and modest capital expenditure requirements. The total net leverage covenant (max 6.00:1) was complied with as of quarter-end.
As of December 31, 2025, BellRing Brands held $64.1M in cash and cash equivalents (plus $12.9M restricted cash). Total debt (principal) stood at $1,190.0M, consisting of $840.0M in 7.00% senior notes due 2030 and $350.0M drawn on the revolving credit facility. The company's stockholders' deficit was $(510.7)M, driven by significant treasury stock. Inventory increased sharply to $435.2M from $330.4M at fiscal year-end, a $104.8M build.
The filing does not disclose long-term purchase commitments or capacity agreements. However, Note 13 details legal contingencies: the Joint Juice litigation resulted in estimated liabilities of $88.0M included in other current liabilities. The company reached settlements in principle and paid $2.0M in Q1 2026 for the New York case, with potential additional payments of $17.2M (New York) and $70.8M (multistate) subject to final approval.
During the quarter, BellRing repurchased 3.0 million shares for $97.8M (average price $31.95). No new buyback authorization was announced. The company also increased net debt by $100.0M ($180.0M borrowed, $80.0M repaid) under its revolving credit facility, which now has available capacity of $147.6M (after $2.4M in letters of credit). Capital expenditures were $4.2M (0.8% of sales).
The company operates as a single reportable segment. The CODM evaluates performance using consolidated net earnings. Quarterly net sales were $537.3M, up 0.8% YoY. Cost of goods sold was $376.5M, advertising $12.4M, amortization $4.3M, other segment expenses $65.6M, interest $20.0M, and tax $14.8M, resulting in net earnings of $43.7M. No geographic breakdown is provided.
Operating cash flow sharply deteriorated to a use of $3.1M in Q1 FY2027 versus a source of $3.0M in the prior year, despite net earnings of $43.7M (down from $76.9M). The divergence reflects a massive $104.7M inventory build, along with an increase in receivables of $22.5M, partly offset by a $69.9M increase in payables. Capex rose to $4.2M (1.3M prior), indicating higher investment intensity. Free cash flow (CFO minus capex) would be negative $7.3M, compared to positive $1.7M last year, but the filing does not explicitly state FCF. Financing activities used $5.3M, driven by $96.9M in treasury stock purchases, funded partly by net debt proceeds of $100M (issuances $180M less repayments $80M). The working capital drain and elevated capex highlight near-term cash pressure, though the company continues to return capital to shareholders via repurchases.